Although EGFR is the most commonly overexpressed tyrosine kinase receptor in head and neck cancer, also other receptors are overexpressed like HER2, HER3, and IL-6 receptor[20,21], which could possibly play a role in hypoxia-induced activation of AKT. Here, ERBB2 is linked to head and neck cancer.